- Category
- Micro (2023-24)
- Udyam number
- UDYAM-TS-20-0027508

Sanguine Inno-Tech Solutions Private Limited
About Sanguine Inno-Tech Solutions Private Limited
Data last updated:
Sanguine Inno-Tech Solutions Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the electronics manufacturing segment of the consumer electronics and durables sector. It was incorporated on 23 June 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U74999TG2020PTC141066.
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹2 Lakh. It is led by directors including Deivya Mohanty and Sambaiah Sadhu.
Its last annual general meeting (AGM) was held on 20 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No:16/1/29 2nd Floor Ip Nacharam, Hyderabad, Telangana, India – 500076.
As per the financials filed for FY 2025, the company reported a revenue of ₹5.79 Cr, a decline of 68% compared to the previous year. For the same year it recorded a net profit of ₹13.2 Lakh (net margin 2.3%) and EBITDA of ₹19.04 Lakh (EBITDA margin 3.3%). Revenue has grown at a compounded annual rate (CAGR) of 81% over three years.
Sanguine Inno-Tech Solutions Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-20-0027508).
Company details
Recognitions & Rankings of Sanguine Inno-Tech Solutions
Contact details
Sanguine Inno-Tech Solutions Private Limited's registered office is in Hyderabad, Telangana.
- Registered AddressPlot No:16/1/29 2nd Floor Ip Nacharam, Hyderabad, Telangana, India – 500076
- IndustryConsumer Electronics & Durables, Electronics Manufacturing
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Sanguine Inno-Tech Solutions is professional, scientific and technical. In detail, this covers other professional, scientific and technical activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M9 | Other professional, scientific and technical activities |
To see the full business activity and turnover split of Sanguine Inno-Tech Solutions Private Limited, buy the company report.
Financials of Sanguine Inno-Tech Solutions Private Limited
FY 2025 filings availableSanguine Inno-Tech Solutions Private Limited reported revenue of ₹5.79 Cr (down 68% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 68% in the latest year, but over three years it has grown at a compounded annual rate (CAGR) of 81%. EBITDA fell 53% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹19.04 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹13.2 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3.3% | ||||
| Net Profit Margin | 2.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Sanguine Inno-Tech Solutions Private Limited, buy the company report.
Board of directors of Sanguine Inno-Tech Solutions Private Limited
Sanguine Inno-Tech Solutions has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Deivya Mohanty | Director | 23 Jun 2020 | 6 Years 4 Months | Current |
| Sambaiah Sadhu | Director | 23 Jun 2020 | 6 Years 4 Months | Current |
| Maddula Sivarama Krishna Also directs: Indriva Techsol Private Limited | Director | 22 Apr 2022 | 4 Years 6 Months | Current |
Legal cases
No court or tribunal cases involving Sanguine Inno-Tech Solutions Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Sanguine Inno-Tech Solutions Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Sanguine Inno-Tech Solutions Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Sanguine Inno-Tech Solutions Private Limited has 5 board changes on record since 2020: 4 appointments and 1 cessation. The latest: Raja Sree Venkata Gopala Krishna ceased to be Director on 26 Jul 2025.
Frequently asked questions
Sanguine Inno-Tech Solutions is an active private limited company based in Hyderabad, Telangana, India. The company works in electronics manufacturing, within the consumer electronics and durables industry. It was incorporated on 23 June 2020 (6+ years old) and is registered under CIN U74999TG2020PTC141066.
Sanguine Inno-Tech Solutions has 3 current directors:
- Deivya Mohanty - Director
- Sambaiah Sadhu - Director
- Maddula Sivarama Krishna - Director
The latest financial statements of Sanguine Inno-Tech Solutions on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 20 September 2025. Year-wise statements from FY 2021 are in the company report.
The CIN (Corporate Identification Number) of Sanguine Inno-Tech Solutions is U74999TG2020PTC141066. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Sanguine Inno-Tech Solutions was incorporated on 23 June 2020, making it 6+ years old. It is registered with the Registrar of Companies, Hyderabad.
Raja Sree Venkata Gopala Krishna ceased to be Director on 26 Jul 2025. Maddula Sivarama Krishna was appointed as Director on 22 Apr 2022. Raja Sree Venkata Gopala Krishna was appointed as Director on 21 Aug 2020. Sanguine Inno-Tech Solutions has 5 board changes on record in total.
Yes, Sanguine Inno-Tech Solutions is registered as a micro enterprise under Udyam registration (number: UDYAM-TS-20-0027508).
The registered office of Sanguine Inno-Tech Solutions is at Plot No:16129 2nd Floor Ip Nacharam, Hyderabad, Telangana, India – 500076.
Sanguine Inno-Tech Solutions operates in the consumer electronics and durables industry, in the electronics manufacturing segment.
Sanguine Inno-Tech Solutions can be reached at its registered office: Plot No:16129 2nd Floor Ip Nacharam, Hyderabad, Telangana, India – 500076.

